
CAS 914454-01-6: Exenatide acetate
Fórmula:C2H4O2·xUnspecified
- Sinónimos:
- L-Serinamide, L-histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-asparaginylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-, acetate (1:?)
- Exenatide acetate
- Exendin-4 acetate
- Exendin 4 (Heloderma suspectum), acetate
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
![]() | Exendin-4 acetate REF: TM-T8748CAS: 914454-01-6 | 98.65% | 67,00 €~620,00 € | Seg 17 Mar 25 |
![]() | Exendin-4 Acetate REF: 3D-PLB45401CAS: 914454-01-6 | Min. 95% | A consultar | Seg 21 Abr 25 |

Exendin-4 acetate
CAS:914454-01-6
Exendin-4 acetate is a 39 amino acid peptide.Exendin-4 acetate is a long-acting GLP-1 receptor agonist(IC50 …
Fórmula:
C186H286N50O62S
Pureza:
98.65%
Cor e Forma:
Solid
Peso molecular:
4247
Ref: TM-T8748
1mg | 67,00 € | ||
5mg | 138,00 € | ||
10mg | 197,00 € | ||
25mg | 281,00 € | ||
50mg | 420,00 € | ||
100mg | 620,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 17 de Março de 2025

Exendin-4 Acetate
CAS:914454-01-6
Exendin-4 acetate is a peptide hormone that belongs to the glucagon family. It is a …
Fórmula:
C186H286N50O62S
Pureza:
Min. 95%
Peso molecular:
4,246.62 g/mol
Ref: 3D-PLB45401
5mg | 655,00 € | ||
10mg | 999,00 € | ||
25mg | 1.763,00 € | ||
50mg | 2.820,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 21 de Abril de 2025